 - Previous therapy with cetuximab for the treatment of recurrent andor metastatic SCCHN. Previous therapy with cetuximab during definitive radiation therapy for locally advanced SCCHN is permitted so long as relapse of SCCHN occurred at least 6 months 180 days from the end of cetuximab therapy. 